LifeMD (LFMD) vs Strata Critical Medical (SRTA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Strata Critical Medical (SRTA) has outperformed LifeMD (LFMD) over the past year, gaining 8.6% versus a loss of 62.5%. Over five years, SRTA leads with a -46.8% price change compared with -65.9% for LFMD. Strata Critical Medical is the larger company by market cap ($407.3 million vs $69.8 million), about 5.8 times the size.
Strata Critical Medical converts more of its revenue into profit, with a net margin of 21.0% versus 7.4%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LFMD | SRTA |
|---|---|---|
| Share price | $1.45 | $4.56 |
| Market cap | $69.84M | $407.30M |
| 1-day change | -9.40% | -5.59% |
| YTD return | -57.62% | -5.20% |
| 1-year return | -62.47% | +8.57% |
| 5-year return | -65.92% | -46.79% |
| Forward P/E | 9.32 | — |
| EPS (TTM) | $-0.52 | $-0.24 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $194.06M | $197.14M |
| Revenue growth (YoY) | +25.34% | +34.28% |
| Net income (latest FY) | $14.35M | $41.35M |
| Gross margin | 85.72% | 20.86% |
| Operating margin | -3.95% | -11.34% |
| Net margin | 7.40% | 20.97% |
| 52-week high | $5.38 | $6.50 |
| 52-week low | $1.38 | $3.95 |
| Distance from 52-week high | -73.14% | -29.85% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +462.63% | +111.18% |
| Average volume | 929.40K | 982.75K |
| Shares outstanding | 48.33M | 89.32M |
| Employees | 347 | 327 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Strata Critical Medical is about 5.8 times larger than LifeMD by market value ($407.30M vs $69.84M).
- SRTA has outperformed LFMD by 71.0 percentage points over the past year.
- Strata Critical Medical is more profitable, keeping 21.0 cents of every revenue dollar as net income versus 7.4 cents for LifeMD.
- Strata Critical Medical grew revenue faster in its latest fiscal year (+34.28% vs +25.34%).
About LifeMD
LFMD stock →LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States.
Health Care · Medical/Nursing Services · 347 employees
About Strata Critical Medical
SRTA stock →Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States.
Health Care · Medical/Nursing Services · 327 employees
LFMD vs SRTA FAQ
Which is bigger, LifeMD or Strata Critical Medical?
Strata Critical Medical (SRTA) is larger, with a market capitalization of $407.30M compared with $69.84M for LifeMD (LFMD).
Which stock has performed better over the past year, LFMD or SRTA?
SRTA returned +8.57% over the past 12 months, compared with -62.47% for LFMD (price return, excluding dividends). Past performance does not predict future results.
Are LifeMD and Strata Critical Medical in the same industry?
Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.